Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,782 | -39,397 | -121,821 | -82,538 | -53,188 |
| Depreciation Amortization | 767 | 441 | 1,974 | 1,454 | 972 |
| Income taxes - deferred | -171 | -202 | -964 | -762 | -974 |
| Accounts payable and accrued liabilities | 1,104 | -504 | 2,458 | 2,027 | 2,428 |
| Other Working Capital | -14,202 | -8,616 | -35,401 | -36,572 | -32,724 |
| Other Operating Activity | 11,902 | 6,717 | 21,927 | 15,277 | 12,470 |
| Operating Cash Flow | $-82,382 | $-41,561 | $-131,827 | $-101,114 | $-71,016 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19,341 | -10,666 | -30,336 | -21,464 | -12,744 |
| PPE Investments | -3,975 | -1,999 | -16,095 | -11,281 | -6,490 |
| Other Investing Activity | -170 | 0 | -665 | -664 | -664 |
| Investing Cash Flow | $15,196 | $-12,665 | $-47,096 | $-33,409 | $-19,898 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 143 | 68 | 185,536 | 63 | N/A |
| Other Financing Activity | 0 | 0 | -4,042 | -2,642 | -1,896 |
| Financing Cash Flow | $143 | $68 | $181,494 | $-2,579 | $-1,896 |
| Beginning Cash Position | 201,116 | 201,116 | 198,545 | 198,545 | 198,545 |
| End Cash Position | 134,073 | 146,958 | 201,116 | 61,443 | 105,735 |
| Net Cash Flow | $-67,043 | $-54,158 | $2,571 | $-137,102 | $-92,810 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,382 | -41,561 | -131,827 | -101,114 | -71,016 |
| Capital Expenditure | -3,975 | -1,999 | -16,095 | -11,281 | -6,490 |
| Free Cash Flow | -86,357 | -43,560 | -147,922 | -112,395 | -77,506 |